Tibet AIM Pharm. Inc.

SZSE:002826 Stock Report

Market Cap: CN¥2.1b

Tibet AIM Pharm Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Zhou Min

Chief executive officer

CN¥561.9k

Total compensation

CEO salary percentagen/a
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates

What Tibet AIM Pharm. Inc.'s (SZSE:002826) 28% Share Price Gain Is Not Telling You

Nov 26
What Tibet AIM Pharm. Inc.'s (SZSE:002826) 28% Share Price Gain Is Not Telling You

Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality

Nov 06
Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality

Some Confidence Is Lacking In Tibet AIM Pharm. Inc.'s (SZSE:002826) P/E

Jun 07
Some Confidence Is Lacking In Tibet AIM Pharm. Inc.'s (SZSE:002826) P/E

Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality

May 02
Investors Can Find Comfort In Tibet AIM Pharm's (SZSE:002826) Earnings Quality

Risks Still Elevated At These Prices As Tibet AIM Pharm. Inc. (SZSE:002826) Shares Dive 26%

Feb 29
Risks Still Elevated At These Prices As Tibet AIM Pharm. Inc. (SZSE:002826) Shares Dive 26%

CEO

Zhou Min (37 yo)

1.8yrs

Tenure

CN¥561,900

Compensation

Ms. Zhou Min serves as Financial Director & Director of Tibet AIM Pharm. Inc. since February 10, 2023 and has been its General Manager since April 24, 2024.

Board Members

NamePositionTenureCompensationOwnership
Zhou Min
GM, Financial Director & Director1.9yrsCN¥561.90kno data
Ke Xu
Chairman3.3yrsCN¥705.00k0.66%
CN¥ 13.7m
Zhan Zhou
Vice Chairman10yrsCN¥301.00k7.83%
CN¥ 162.0m
Yu Zhang
Director3.3yrsCN¥284.30k0.20%
CN¥ 4.2m
Ming Hu
Independent Director3.3yrsCN¥200.00kno data
Xinggang Xiao
Independent Director3.3yrsCN¥200.00kno data
Lan Feng
Independent Director3.3yrsCN¥200.00kno data
Ling Li
Chairman of the Supervisory Board3.3yrsno data0.25%
CN¥ 5.1m
Zhongbin Wang
Non-Employee Supervisor3.3yrsno datano data

3.3yrs

Average Tenure

46yo

Average Age

Experienced Board: 002826's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:26
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tibet AIM Pharm. Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution